Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Clinical trial NCT02147951 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT02147951
- Sponsor
- Amgen
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.